Early effects of aspirin desensitization treatment in asthmatic patients with aspirin-exacerbated respiratory disease

  • Berges-Gimeno M
  • Simon R
  • Stevenson D
  • 19


    Mendeley users who have this article in their library.
  • 68


    Citations of this article.


Background: Aspirin (ASA)-exacerbated respiratory disease (AERD) is characterized by aggressive inflammation of the respiratory tract and often requires topical and/or systemic corticosteroids to maintain partial control of this disease. Previous studies have revealed that ASA desensitization and subsequent treatment with ASA is associated with clinical improvement in AERD. Objective: The aim of the present study was to determine the effect of daily ASA treatment for the first 4 weeks after ASA desensitization. Methods: Thirty-eight patients underwent ASA oral challenge followed by ASA desensitization and daily ASA therapy. Changes in nasal and asthma symptoms, combined with changes in oral prednisone, were recorded daily during 4 weeks before and after desensitization. Severity of symptoms ranged from a scale of 1 to 5 (1 = asymptomatic and 5 = most severe symptoms). For statistical analyses the sum of nasal symptoms and asthma symptoms was calculated. Olfactory scores were also analyzed. Results: Nasal and asthma symptom scores, as well as olfactory scores, improved significantly (P < 0.0001). For the 15 patients taking prednisone, their mean doses decreased from 10.7 to 5.9 mg daily (P = 0.0003). Conclusions: Our study suggests that ASA desensitization treatment is effective during the first 4 weeks of daily treatment with ASA.

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • M. Pilar Berges-Gimeno

  • Ronald A. Simon

  • Donald D. Stevenson

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free